Breckenridge Pharmaceutical Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ETHACRYNIC ACID USP, with a corresponding US DMF Number 27473.
Remarkably, this DMF maintains an Active status since its submission on September 03, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 15, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II